Skip to main content
. 2024 Sep 23;17(4):371–377. doi: 10.3400/avd.oa.24-00061

Fig. 1 Continue rates of DOAC. The continued rates of DOAC were 88.4%, 45.1%, 15.2%, and 11.6% in days 30, 90, 180, and 365, respectively. Approximately half of the patients discontinued DOACs within 90 days. DOAC: direct oral anticoagulant.

Fig. 1 Continue rates of DOAC. The continued rates of DOAC were 88.4%, 45.1%, 15.2%, and 11.6% in days 30, 90, 180, and 365, respectively. Approximately half of the patients discontinued DOACs within 90 days. DOAC: direct oral anticoagulant